Marinus Pharmaceuticals Is A Biopharmaceutical Company Based In Radnorpennsylvaniafocused On Developing Innovative Treatments For Severerare Forms Of Epilepsy And Other Seizure Disordersfounded In 2003The Company Is Publicly Traded On Nasdaq Under The Ticker Mrnsits Mission Is To Improve The Lives Of Patients With Seizure Disorders Through Collaboration With Patientscaregiversand Healthcare Professionals The Company S Lead Productztalmyganaxolone Is An Oral Suspension Approved By The Fda For Treating Seizures Associated With Cyclin Dependent Kinase Like 5 Deficiency Disordercdkl5In Both Adults And Childrenmarinus Is Also Advancing Ganaxolone For Other Genetic Epilepsy Disordersincluding Pcdh19 Related Epilepsy And Tuberous Sclerosis Complexas Well As For Status Epilepticusthe Company Markets Its Products To Healthcare Providers And Has Established Partnerships With Various Organizations To Enhance Its Research And Development Efforts
No conferences found for this company.
| Company Name | Marenis Pharma Gmbh |
| Country |
Germany
|
| Address | Schillerstrasse 1 55411 Bingen Am Rhein Germany |
| Telephone | Login to View |
| Login to View |
